← Back to Search

Behavioral Intervention

Cognitive Training for Face Blindness

N/A
Recruiting
Research Sponsored by Harvard Medical School
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Developmental prosopagnosic participants will be included if they are aged 18-65, have lifelong histories of face recognition difficulties that impact their everyday life (i.e., not associated with some event such as a stroke, seizure, etc), and score > 2 standard deviations below the mean on the famous faces test and Cambridge Face Memory Test. This is in line with our previous studies and others in the literature.
Developmental prosopagnosic participants aged 18-90
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights

Study Summary

This trialwill test if a special training can help people with difficulty recognizing faces to improve their face recognition skills.

Who is the study for?
This trial is for adults aged 18-65 with Developmental Prosopagnosia, a condition where they have lifelong difficulties recognizing faces, impacting daily life. They must perform poorly on specific face recognition tests. Excluded are those with substance dependence, significant neurological disorders, sensory impairments, severe psychiatric conditions or recent participation in other interventions.Check my eligibility
What is being tested?
The study is testing a cognitive training program designed to improve the ability to remember and recognize faces in people with Developmental Prosopagnosia. The effectiveness of this 'repetition lag training' will be measured against standard face recognition tests.See study design
What are the potential side effects?
Since the intervention involves cognitive exercises rather than medication or invasive procedures, no physical side effects are expected. Participants may experience mental fatigue or frustration during the training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have always had trouble recognizing faces, not due to an event like a stroke, and I am between 18-65 years old.
Select...
I have difficulty recognizing faces and am between 18 and 90 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cambridge Face Memory Test
Face Perception
Face Recollection
Secondary outcome measures
Face-name learning task
Self-reported face recognition

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: holistic face training + repetition lag trainingExperimental Treatment1 Intervention
Group II: waitlist controlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
cognitive training
2020
N/A
~420

Find a Location

Who is running the clinical trial?

Harvard Medical SchoolLead Sponsor
29 Previous Clinical Trials
40,789 Total Patients Enrolled
Harvard Medical School (HMS and HSDM)Lead Sponsor
195 Previous Clinical Trials
1,316,669 Total Patients Enrolled
Boston VA Research Institute, Inc.Lead Sponsor
22 Previous Clinical Trials
10,746 Total Patients Enrolled

Media Library

Repetition Lag Training (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04799340 — N/A
Face Blindness Research Study Groups: waitlist control, holistic face training + repetition lag training

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this research open to those aged 75 and over?

"This medical study is looking for people of age 18 or older but not exceeding 90 years."

Answered by AI

Are there any openings remaining in this research project?

"Affirmative. According to the clinicaltrials.gov website, this medical trial began recruiting on March 12th 2021 and is still ongoing as of November 23rd 2022. For now, 60 volunteers are being accepted at a single site."

Answered by AI

Am I eligible to be a test subject in this experiment?

"The prerequisites to join this medical research require that the participants have been diagnosed with prosopagnosia, and be between 18-90 years old. The trial is aiming for a cohort of 60 people."

Answered by AI

Could you kindly provide the number of participants in this research trial?

"Indeed, clinicaltrials.gov states that this research is presently enrolling participants. The trial was advertised on March 12th 2021 and the most recent update was made November 23rd 2022. 60 individuals are needed to be recruited from 1 centre in total."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
~17 spots leftby May 2025